Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer
Clinical trial NCT00615940 · COMPLETED
Trial details
- NCT number
- NCT00615940
- Sponsor
- Heidelberg Pharma AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2011-12-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.